Navigation Links
Rothwell, Wolf Elected to Codexis Board

REDWOOD CITY, Calif., Dec. 12 /PRNewswire/ -- Codexis, Inc., a leading developer of clean technology manufacturing processes, today announced two new directors have been named to the company's Board of Directors. Joining the Board are Bill Rothwell, Ph.D., Vice President of Innovation and Chemicals Technology, Shell Global Solutions, a unit of Royal Dutch Shell plc and Dennis Wolf, Executive Vice President and CFO, MySQL, a leading open source database company.

"Our new directors bring valuable expertise to Codexis at an important point in our company's growth," said Alan Shaw, Ph.D., President and Chief Executive Officer. "Bill Rothwell has nearly 30 years experience managing and leading technology innovation at Shell. He joins us as part of our extended collaboration with Shell in biofuels, announced November 6. Dennis Wolf, a seasoned finance executive in high growth public technology companies, will bring Codexis valuable experience and perspective. We are very pleased to welcome both of them to our Board."

Dr. Rothwell is based in Houston and has global responsibility for identifying and leveraging innovation and chemical technology across the Shell Group, including all biodomain research. He sits on both the Shell Global Solutions and Shell Chemicals Leadership Teams. He has a strong technical background combined with extensive experience in strategy and business roles. He joined Shell in 1980 with a Ph.D. in physical chemistry from the Massachusetts Institute of Technology and has undergraduate degrees in mathematics and chemistry from Michigan State University.

In his first decade at Shell, Dr. Rothwell worked as a research manager and research chemist at the Westhollow Technology Centre in Houston. In 1990 he moved to Shell's offices in Houston and over the next seven years worked in a number of strategic planning and business assignments. In 1998 he relocated to London and served as Head of Strategy, Planning and Ventures for Shell Chemicals. In 2002, he was appointed to the position of General Manager of Shell Chemicals global Ethylene Oxide/Glycols business, a position he held until his current appointment earlier this year.

Mr. Wolf has broad executive financial management experience in technology companies at the COO, CFO and Co-CEO level. He currently serves as Executive Vice President and CFO at MySQL, AB, Cupertino, CA. The company produces a leading open source database used by customers to power high volume websites and other business-critical functions. Mr. Wolf is responsible for managing the company's finance operations. Previously, he held financial management positions for public high technology companies including Omnicell, Inc., Credence Systems, Centigram, Apple Computer and Sun Microsystems.

Mr. Wolf holds a bachelor of arts degree from the University of Colorado and an MBA from the University of Denver. He currently serves on the board of Quantum and has been a board member and chair of the audit committee for Nasdaq-listed companies including Komag, Vitria Technology and Registry Magic.

Codexis, Inc. is a leading developer of clean biocatalytic process technologies that can substantially reduce the cost of manufacturing across a broad range of industries. Codexis' proprietary directed evolution technologies enable novel solutions for efficient, cost-effective and environmentally friendly processes for pharmaceutical, energy and industrial chemical applications. In 2006, the company was recognized by the U.S. EPA with a Presidential Green Chemistry Challenge Award. Codexis is a registered trademark of Codexis, Inc. For more information please visit

Contact: Justin Jackson, of Burns McClellan, 212-213-0006, or Lyn Christenson, Codexis,, 650-421-8144.

SOURCE Codexis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Bruce Pasternack Elected to Codexis Board
2. Biomaxx Systems Inc. Selected as Technical Consultant By Southern Cross Agricultural Developments
3. Solazyme, Inc. Selected by AlwaysOn as a GoingGreen 100 Top Private Company Award Winner
4. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project
5. AG Mednet Selected By Massachusetts General Hospital to Transport 3D Post-Processing Images
6. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
7. Arena Pharmaceuticals Selected to Join New NASDAQ NeuroInsights Neurotech Index
8. Solazyme Selected for National Institute of Standards and Technology Award
9. Advanced Life Sciences to Present Data from Selected Cethromycin Clinical Trials at the 45th Annual Meeting of the Infectious Diseases Society of America
10. Genstructs Andrea Matthews Selected for Mass High Techs People to Watch Under 30
11. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
Post Your Comments:
(Date:10/12/2015)... 2015 cell surface marker detection market ... according to a new report by Grand View Research, Inc. ... incidence of oncology diseases and other cell-associated disorders. --> ... reach USD 6.49 billion by 2022, according to a new ... can be attributed to rise in incidence of oncology diseases ...
(Date:10/12/2015)... 12, 2015 LabStyle Innovations Corp. ... Solution, today announced its Medical Director, Dr. Moshe ... MobiHealth,s 5th EAI International Conference on Wireless Mobile ... innovations in mobile and wireless technologies," the conference will ... from October 14 - 16, 2015. The conference is ...
(Date:10/12/2015)... ... 2015 , ... NeuMedics Inc., is a specialty biopharmaceutical company focused on identifying ... chronically be administered as an eye drop, announced today it has been selected to ... taking place October 25th to October 28th at The Cleveland Clinic, Cleveland, Ohio. ...
(Date:10/10/2015)... Maryland , 10. Oktober, 2015 ... Matsui (Abgeordnete der Demokratischen Partei für Kalifornien) ihre ... bis 17. Oktober) in die Aufzeichnungen des Kongresses ... Plasma Protein Therapeutics Association (PPTA) und ihren ... , Hebung des Bewusstseins über Plasmaspenden weltweit ...
Breaking Biology Technology:
(Date:9/10/2015)... Pursuant Health has collaborated with health ... interactive, image-based health risk assessment (HRA) optimized for ... unique assessment quantifies user results into an easily ... individual,s biological age based on personal health habits, ... kiosk. Comprised of age, gender, and ...
(Date:9/9/2015)... , Sept. 9, 2015  NuData Security announced ... solution-based milestones, furthering the company,s commitment to protecting ... fraud. NuData Security,s online fraud detection ... company,s growth cycle. The product combines continual analysis ... good user behavior from fraudulent behavior, allowing the ...
(Date:9/8/2015)... , Sept. 8, 2015  Affectiva, global ... Emotion as a Service, a new data solution, ... Based on Affectiva,s highly accurate and patented ... analytics capabilities, slated to transform industries such as ... development, retail, customer experience, online education, HR, automotive, ...
Breaking Biology News(10 mins):